Treatment-resistant depression (TRD) is a complex form of clinical depression that doesn’t respond adequately to standard depression treatments[1]. While many people find relief through traditional approaches like antidepressant medication and therapy, approximately 30% of individuals with depression experience persistent symptoms despite multiple treatment attempts[2]. This challenging condition can leave many feeling hopeless, but there are specialized approaches and emerging treatments offering new pathways to recovery.
At Monima Wellness, we understand the unique challenges women face when struggling with treatment-resistant depression. Our comprehensive, gender-specific approach addresses not only the symptoms but also the underlying factors that may contribute to lingering depression, offering renewed hope for those who have struggled to find relief through conventional methods. We are proud to provide ketamine therapy (Spravato®) as an option for qualified candidates enrolled in our outpatient treatment programs.
Treatment-resistant depression is typically defined as depression that hasn’t improved significantly after at least two adequate trials of different antidepressant medications taken at proper doses for a sufficient duration (usually 6-8 weeks per trial)[1]. However, many clinicians recognize that this definition can be too narrow, as treatment resistance exists on a spectrum and can involve various factors beyond medication response.
A more comprehensive understanding of TRD acknowledges that resistance may involve:
It’s important to note that TRD is not a reflection of personal failure or weakness. Instead, it represents the complex biological, psychological, and social factors that can influence depression and its treatment response.
Treatment-resistant depression includes the same core symptoms as major depressive disorder, but they persist despite treatment attempts. These may include:
For those with TRD, these symptoms may:
Treatment-resistant depression rarely has a single cause. Instead, multiple factors typically contribute to both the depression itself and the challenges in treating it effectively. Understanding these various factors can help develop more targeted and effective treatment approaches.
Contact us today at 858-500-1542 to begin crafting your path to recovery.
Women face unique challenges regarding treatment-resistant depression that require specialized understanding and approaches. Gender-specific factors can significantly impact both the presentation of depression and the effectiveness of various treatments.
Female hormonal fluctuations throughout the lifespan can significantly impact depression and treatment response:
Women may experience higher rates of certain forms of trauma, including sexual violence and intimate partner abuse, which can significantly impact depression treatment[3]:
Research has identified concerning disparities in depression treatment for women:
At Monima Wellness, our women-centered approach recognizes these unique factors.
Our programs are specifically designed to address the complex interplay of biological, psychological, and social factors that can contribute to treatment-resistant depression in women.
Effective treatment for TRD begins with a thorough assessment. A comprehensive evaluation is essential for identifying specific factors contributing to treatment resistance and developing a targeted treatment plan.
Monima offers specialized neuropsychological testing that can provide deeper insights into:
Our trauma-informed approach includes evaluation of:
This comprehensive approach allows us to create truly individualized treatment plans that address the unique factors contributing to each woman’s treatment-resistant depression.
Evidence-Based Treatment Approaches to TRD
Effectively addressing treatment-resistant depression typically requires a multifaceted approach that goes beyond standard depression treatments. A combination of medical, psychological, and holistic interventions often yields the best results for complex cases of depression.
For those who haven’t responded adequately to standard antidepressants, several medication strategies may be considered:
Our psychiatric team specializes in carefully managed medication approaches that consider the unique aspects of women’s neurochemistry and hormonal influences.
Certain therapeutic approaches have shown particular promise for treatment-resistant depression:
For many women with treatment-resistant depression, addressing underlying trauma is critical for recovery:
For severe treatment resistant depression, several innovative approaches have shown promising results:
At Monima Wellness, we believe in addressing the whole person—body, mind, and spirit—through integrative approaches that complement evidence-based treatments:
Monima Wellness offers several levels of care for women with treatment-resistant depression, allowing for tailored treatment intensity based on individual needs:
Our most intensive level of outpatient care provides comprehensive support through a structured schedule 5 days per week for 6 hours per day. The PHP includes daily therapy groups, regular individual sessions, psychiatric care, and medication management, all while allowing you to return home each evening. Clients have access to ketamine therapy as part of our comprehensive approach to treatment resistant depression. This level of care is ideal for women who need intensive support but don’t require 24-hour inpatient care.
A step down from PHP, our IOP offers treatment 3-5 days per week for 3 hours per day, allowing you to maintain work or family responsibilities while still receiving significant support. The program includes regular therapy groups, weekly individual sessions, and psychiatric monitoring. Clients also have access to ketamine therapy as part of our treatment approach for depression that hasn’t responded to standard interventions. This level provides balanced support with greater independence for women in various stages of recovery.
For women who would benefit from a supportive living environment during treatment, Monima partners with Ohana Residencies to provide optional transitional housing. This arrangement offers structured community support with others in recovery, creating stability during the treatment process. The proximity to our treatment center ensures convenient access to all therapeutic services, including our specialized treatments for resistant depression.
Recovery from treatment-resistant depression is not just about symptom reduction but about creating a meaningful life even in the presence of challenges. At Monima, we support women in developing comprehensive recovery strategies:
While treatment-resistant depression presents significant challenges, there is substantial reason for hope. Advances in our understanding of depression’s complex nature have led to more effective, personalized approaches to treatment.
At Monima Wellness, we’ve seen many women find their way forward after years of struggling with treatment-resistant depression. Our integrated approach—combining medical expertise, evidence-based therapies, trauma-informed care, and holistic practices—provides multiple pathways to healing.
We understand that each woman’s journey with depression is unique, and we’re committed to walking alongside you on your path to recovery. Our clinical team creates a safe, understanding environment where women can explore all aspects of their experience and find renewed hope.
Recovery is possible, even if past treatments haven’t provided the relief you deserve. Let us help you find your path forward.
Call us at (858) 500-1542 to learn more about our approach or to schedule a consultation. Our admissions team can help determine the most appropriate level of care for your unique situation and guide you through starting treatment.
Contact us today at 858-500-1542 to begin crafting your path to recovery.
[1] McIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., Ly-Uson, J., Mansur, R. B., McAllister-Williams, R. H., Murrough, J. W., Nemeroff, C. B., Nierenberg, A. A., Rosenblat, J. D., Sanacora, G., Schatzberg, A. F., Shelton, R., … Maj, M. (2023). Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World psychiatry : official journal of the World Psychiatric Association (WPA), 22(3), 394–412. https://doi.org/10.1002/wps.21120
[2] Al-Harbi K. S. (2012). Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient preference and adherence, 6, 369–388. https://doi.org/10.2147/PPA.S29716
[3] World Health Organization. (2021, March 9). Violence against women. Retrieved from https://www.who.int/news-room/fact-sheets/detail/violence-against-women
[4] Romanescu, M., Buda, V., Lombrea, A., Andor, M., Ledeti, I., Suciu, M., Danciu, C., Dehelean, C. A., & Dehelean, L. (2022). Sex-Related Differences in Pharmacological Response to CNS Drugs: A Narrative Review. Journal of personalized medicine, 12(6), 907. https://doi.org/10.3390/jpm12060907